Structure and function of a novel bacterial immune system
Ended Project Grant Awarded Last action
- Award ID
- F31AI181575
- Recipient
-
The Ohio State University UEI DLWBSLWAJWR1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $120,218
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Ohio, USA
Award details come from USAspending.gov.
Description
- Abstract
- The constant arms race between viruses and their hosts lead to the evolution of antiviral defense. Recent studies have revealed that bacteria developed diverse anti-phage defense systems that can be denoted as the "prokaryotic immune systems". The well-characterized prokaryotic immune systems include restriction- modification (r-m) systems, crispr-CAS systems, abortive infection systems, and prokaryotic argonautes. Mechanistic characterization of these systems has revolutionized biomedical research. For example, r-m systems provide restriction enzymes as invaluable tools for molecular cloning and genetic engineering while crispr-CAS has revolutionized the genome-editing field. In this proposal, we will focus on characterizing a novel bacteria immune system with unknown mechanisms. In this system, we have two components: a and b. A is predicted to have an atpase domain, while b is predicted to be a nuclease. Our preliminary study showed that a and b can form a stable and large complex for anti-phage defense. This finding is reminiscent of inflammasomes, which are large immune complexes that are assembled via the atpase domain in response to pathogen infection in higher organisms. We hypothesized that a and b also form large oligomers to combat phage infection. We will use cutting-edge cryogenic electron microscopy single-particle analysis techniques to define the structure and assembly mechanisms of the a/b complex and develop biochemical and cellular assays to characterize the functions of the a/b complex. Our studies will provide a mechanistic understanding of the assembly and functions of this novel inflammasome-like system in bacteria, which will shed light on the evolution of inflammasome signaling as well as provide a basis to develop novel tools for biomedical research and disease diagnosis and treatment.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$4,942 | |
| Amendment | -$23,936 | |
| Amendment | $1,280 | |
| Amendment | $0 | |
| Amendment | $1,280 | |
| Amendment | $0 | |
| Amendment | $1,280 | |
| Amendment | $36,314 | |
| Amendment | $36,314 | |
| Amendment | $36,314 | |
| Original award | $36,314 |
Show all 11
Quick answers
Who received award F31AI181575?
F31AI181575 was awarded to The Ohio State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 21, 2024.
How much is award F31AI181575 worth?
$120,218 has been obligated on F31AI181575.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award